Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-050075

bluebird bio, Inc. · BLUE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Philip D Gregory
Officer — Chief Scientific Officer
Period of report
Sep 5, 2018
Accepted (ET)
Sep 7, 2018 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockSep 5, 2018M600$50.51A32,971D
Common StockSep 5, 2018M700$75.60A33,671D
Common StockF2Sep 5, 2018S777$161.8295D32,894D
Common StockF3Sep 5, 2018S510$162.9039D32,384D
Common StockF4Sep 5, 2018S213$164.0317D32,171D
Common StockF5Sep 5, 2018S200$165.275D31,971D
Common StockSep 5, 2018S100$166.25D31,871D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F6$50.51Sep 5, 2018M600D—Mar 1, 2026Common Stock60015,800D
Stock Option (right to buy)F7$75.60Sep 5, 2018M700D—Feb 1, 2027Common Stock70032,700D

Explanation of responses